22 July 2020Muireann Bolger

LSPN Connect: artificial intelligence and IP

Artificial Intelligence (AI) offers exciting and unprecedented opportunities for life sciences and healthcare but also poses complex questions for the IP sector, as an LSPN Connect session discovered yesterday, July 21.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

EPO affirms that AI cannot invent

22 December 2021 The European Patent Office has ruled that only humans can invent, dismissing appeals looking to list an artificial intelligence as a named inventor on a patent.

Patents

Only humans can invent, says judge in first US AI patent decision

6 September 2021 Only a human being can be legally listed on a patent as an inventor, according to a Virginia federal judge who delivered the first US ruling in the worldwide debate on the patentability of AI inventions.

Patents

ECTA: The risks of progress without a plan

3 June 2021 The implications of applying AI solutions must be carefully and fully considered before they are implemented, argues Mladen Vukmir of ECTA.

How BSH v Electrolux is impacting UPC decisions with 'relative ease'

Hitting the right note: Sound trademarks at the EUIPO

Lenovo and Ericsson end all litigation with cross-licence agreement

The UPC, a tiny LED, and the eight-country injunction

BSH Hausgeräte v Electrolux: CJEU confirms UPC's treatment of third-state patents

‘The $1m question’: Coca-Cola counsel on AI’s impact on the client-attorney relationship

Mercedes-Benz fails to register off-road silhouette in EU

Trade secrets: Navigating the maze of definition and regulation

LSPN Connect: artificial intelligence and IP

More on this story

Editor's picks

Editor's picks

More articles